Moreover, serum ZAG levels have been found to be decreased in various obesity-related disorders, including T2DM (36), hypertension (39), premature coronary artery disease (50), and PCOS (41), which further indicates the pivotal role of ZAG in the regulation of metabolism. Here, AZGP1 is linked to type 2 diabetes mellitus.